Stock Talk is a new Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this first edition, host Dr Nigel Finch examines the coronavirus-induced boom of the telehealth industry.

Populating the experts panel this week is David Groberman, CEO and co-founder of HeraMED (ASX:HMD), Marjan Mikel, CEO and managing director of Respiri (ASX:RSH) and Jason Waller, CEO and managing director of InteliCare.

The panel discuss a wide rage of subjects including the advantages of telehealth,  how the impact of COVID-19 and government regulation is driving adoption across the sector and the barriers and bottlenecks the industry faces.

So tune in above to hear the panel answer these questions and more.

Read MoreCOVID-19HealthMedtechTelecommunications

Featured Companies

You might be interested in